Kae Gruner is a food and drug lawyer at McGuire Woods with a focus on advising pharmaceutical, medical device, cannabis, dietary supplement, food and beverage, and healthcare technology companies. She counsels clients on a range of intellectual property, regulatory, data privacy, corporate, and transactional matters.
Kae has substantial experience in developing intellectual property and commercialization strategies from bench-to-bedside, as well as in negotiating commercial agreements for life sciences companies. In addition, she counsels clients on compliance and interactions with FDA, DEA, HHS OIG, and FTC as it pertains to manufacture, marketing, and distribution of products regulated under the Federal Food, Drug, and Cosmetics Act.
In her most recent role as associate counsel for a pharmaceutical company and its subsidiaries, Kae served as the point person for all patent and trademark matters and held significant responsibility for drafting, reviewing, and negotiating contracts for all company affiliates, as well as policies relating to data privacy, licensing, and FDA regulatory compliance. Her experience gives her a unique insight into understanding both life science company compliance as well as transactions. As an in-house counsel she was actively involved in mergers, acquisitions, and capital acquisition with respect to her company’s growth and success.
Kae is a deal focused transactional lawyer with an in-depth understanding of funding and acquisitions in life sciences. She brings a skillset of understanding the transaction and the dual regulatory and intellectual property considerations for products in an acquisition.
Kae frequently speaks and writes about emerging healthcare, business, and technology topics. In addition to her current practice, Kae handles pro bono cases for artists, arts organizations, and early stage small business owners.
Check back soon for more articles by Kae Gruner